Alerts will be sent to your verified email
Verify Email
GENPHARMA
|
Genpharmasec
|
Nureca Ltd.
|
3B Blackbio Dx
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
3.69 % | 33.5 % | 33.92 % |
|
5yr average Equity Multiplier
|
1.26 | 1.74 | 1.4 |
|
5yr Average Asset Turnover Ratio
|
0.81 | 1.65 | 0.63 |
|
5yr Avg Net Profit Margin
|
15.44 % | 9.68 % | 36.24 % |
|
Price to Book
|
7.13 | 1.4 | 2.54 |
|
P/E
|
100.94 | 335.83 | 19.34 |
|
5yr Avg Cash Conversion Cycle
|
167.68 Days | 140.67 Days | 163.91 Days |
|
Inventory Days
|
85.85 Days | 73.5 Days | 41.19 Days |
|
Days Receivable
|
86.95 Days | 11.25 Days | 188.65 Days |
|
Days Payable
|
67.59 Days | 36.21 Days | 63.98 Days |
|
5yr Average Interest Coverage Ratio
|
1.21 | 29.97 | 260.03 |
|
5yr Avg ROCE
|
2.82 % | 42.4 % | 40.11 % |
|
5yr Avg Operating Profit Margin
|
18.2 % | 14.47 % | 50.56 % |
|
5 yr average Debt to Equity
|
0.04 | 0.14 | 0.09 |
|
5yr CAGR Net Profit
|
37.25 % | n/a | 37.7 % |
|
5yr Average Return on Assets
|
2.92 % | 16.71 % | 23.85 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
29.98 % | 63.24 % | 41.29 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-29.98 % | -6.76 % | 2.94 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | -1.63 % | 0.0 |
|
Genpharmasec
|
Nureca Ltd.
|
3B Blackbio Dx
|
|
|---|---|---|---|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
Operating Profit Break-Up
|
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
